131 Followers on Owler
VIR is a biotechnology company that engages in developing and commercializing drugs for serious infectious diseases...
Read moreVIR is a biotechnology company that engages in developing and commercializing drugs for serious infectious diseases...
Read more
News
Mar 08, 2023
Owler
Vir Biotechnology, Inc.: Vir's employee count changed from 444 in Dec 2021 to 576 in Dec 2022
Feb 25, 2023
Americanbankingnews
Vir: Vir Biotechnology (NASDAQ:VIR) Posts Earnings Results, Misses Expectations By $0.72 EPS
Feb 23, 2023
BioSpace
Vir: Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Feb 23, 2023
Yahoo
Vir: Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Misses Revenue Estimates
Feb 16, 2023
Seeking Alpha
Vir: Vir Biotechnology names new CFO
Feb 16, 2023
MarketScreener
Vir: Vir Biotechnology Appoints Sung Lee as Chief Financial Officer
Feb 14, 2023
BioPharma Dive
Vir: GSK backs away from COVID collaboration with Vir
Jan 25, 2023
BioPharma Dive
Vir: Veteran biotech leader George Scangos to step down as Vir CEO
Jan 08, 2023
Seeking Alpha
Vir: Vir Biotechnology: The First Entry In My Long Term Value Portfolio
Jan 03, 2023
MarketScreener
Vir: Vir Biotechnology to Highlight Anticipated 2023 Catalysts and Long-Term Growth Strategy at 41st Annual J.P. Morgan Healthcare Conference
Looking for similar companies to Vir?
Vir Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$1.6B
Vir's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 2.7B. Over the last four quarters, Vir's revenue has grown by 111.5%. Specifically, in Q3 2022's revenue was $374.6M; in Q4 2021, it was $812.8M; in Q3 2021, it was $103.6M; in Q2 2021, Vir's revenue was $177.1M.
Vir News
Vir Press Releases
Vir Headquarters
Vir Summary
ABOUT
Overview
VIR is a biotechnology company that engages in developing and commercializing drugs for serious infectious diseases. Vir was founded in 2016. Vir's headquarters is located in San Francisco, California, USA 94158. Vir's President & CEO, George Scangos...CEO
Vir's President & CEO, George Scangos, currently has an approval rating of 92%. Vir's primary competitors are Morphotek, Appili, XOMA and 17 more.Website
vir.bioCompetitors
View 20 Vir competitors here.Acquisitions
View 2 companies acquired by Vir here.Funding
View Vir funding details.Investments
Recent investment data cannot be found related to VirFrequently Asked Questions about Vir
When was Vir founded?
Vir was founded in 2016Who is Vir's CEO?
Vir's CEO is George ScangosHow much revenue does Vir generate?
Vir generates $1.6B in revenueHow much funding does Vir have?
Vir has historically raised $491.4M in funding
Where is Vir's headquarters?
Vir's headquarters is in San Francisco California, USAHow many employees does Vir have?
Vir has 580 employeesWhat sector does Vir operate in?
Vir is in BiotechnologyWho are Vir's competitors?
Vir's top competitors are Morphotek, Appili, XOMA